ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). Company is founded in early 2019 by four committed founders with a long history in respiratory medicine, medical devices and artificial intelligence. Working on a junction of multidisciplinary fields, founders identified opportunity and value that novel technologies could bring to all parties in a respiratory setting: patients, doctors, healthcare system and industry.
ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.
ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.
Location: Belgium, Flemish Brabant, Leuven
Employees: 1-10
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | KU Leuven ... | lrd.kuleuv... |
Mentions in press and media 2
| Date | Title | Description |
| 19.12.2023 | Who Are Belgium’s Most Influential AI Startups Transforming the Industry? | Belgium, despite being a small nation, has emerged as a vibrant technology hub. Artificial Intelligence (AI), in particular, has risen to prominence, with a growing number of startups specializing in AI technology offering innovative soluti... |
| 19.06.2019 | This Belgian startup raises a million euros to launch a software platform that will detect lung diseases instantly | ArtiQ, an innovative spin-off startup of KU Leuven (Belgium) which helps doctors diagnose, treat and monitor respiratory problems has announced that it has successfully concluded its seed financing round, raising € 1 million. KU Leuven is E... |